Further analysis found that serum VIP levels were not significantly different between the negative cardiovascular symptom subgroup and the cardiovascular symptom subgroup, whereas lower serum VIP levels were detected in the anxiety subgroup and depression subgroup than in the non-anxiety subgroup and non-depression subgroup. Here, VIP is linked to depressive symptom measurement.